NCT00538018View on ClinicalTrials.gov

Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas

PHASE4CompletedINTERVENTIONAL
Enrollment

978

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Pneumonia
Interventions
DRUG

Telithromycin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY